Discovery of MK-8719, A Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies
Inhibition of O-GlcNAcase (OGA) has emerged as a promising therapeutic [...]
Inhibition of O-GlcNAcase (OGA) has emerged as a promising therapeutic [...]
Advances Novel Tau-directed Strategy for Treating Neurodegenerative Disease Phase 1 [...]